All In Biotech

Drug Trial Radar · NCT01080963

Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections

Prospective Randomised Study of Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections After Median Sternotomy

Last checked: Nov 19, 2026Latest source record: Apr 17, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 650 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

650

Actual

Start

Nov 2008

Primary completion

Mar 2012

Study completion Mar 2012

Sponsor

Lead sponsor
Hannover Medical SchoolAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Novartis
First posted
Mar 5, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to show that the incidence of sternal wound infections at day 30 after cardiac surgery is 50% lower with the additional use of Daptomycin on top of a standard antibiotic prophylaxis as compared to the standard antibiotic prophylaxis alone.

Conditions

  • Wound Infection

Interventions

  • DaptomycinDrug

    one infusion of 350 mg intraoperatively after disconnection from the heart-lung machine as an add-on to standard antibiotic prophylaxis

  • CefuroximeDrug

    1500 mg intravenous 30min preoperatively during anesthesia and 1500 mg intravenous intraoperatively after disconnection from the heart-lung machine

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of sternal wound infection is at least 50% lower if Daptomycin is used on top of a standard antibiotic prophylaxis as compared to the standard antibiotic prophylaxis aloneTime frame: day 30

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular surgery

    Hanover, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.